Brain Health
Simufilam Alzheimer's Trial Terminated Before Completing Phase 3
Cassava Sciences' 76-week Phase 3 trial of simufilam for Alzheimer's was terminated, raising questions about the drug's future.
Clinical Trial
Jun 1, 2026 0
All Articles
609 articles
Regenerative Medicine
PRF and CGF Scaffolds Tested Against Blood Clot for Regrowing Dead Tooth Roots
A 12-month RCT compares three scaffold types and two EDTA concentrations for regenerating necrotic immature permanent teeth.
Clinical Trial
May 31, 2026 0
Brain Health
Columbia Study Tests Group-Based Family Nurture Intervention for Preschoolers
A completed Columbia University trial compares Family Nurture Intervention in group settings to standard programs for children ages 2–4.5.
Clinical Trial
May 31, 2026 0
Exercise & Fitness
Combining NR Supplements With Exercise May Finally Unlock NAD+ Benefits in Humans
A completed Maastricht University trial tests whether pairing NR supplementation with exercise can boost NAD+ levels and reverse metabolic dysfunction in overweight adults.
Clinical Trial
May 30, 2026 0
Autoimmune & Arthritis
CanSino's Adenovirus COVID-19 Vaccine Shows Safety and Immune Response in Phase I Trial
A landmark Phase I trial of 108 adults tested the first adenovirus-vectored COVID-19 vaccine for safety and immune response.
Clinical Trial
May 30, 2026 0
Cancer Research
L-Arginine Tested to Restore Erectile Function in Prostate Cancer Radiation Survivors
A phase II trial explores whether the amino acid L-arginine, with or without enzyme inhibitors, can improve erectile function and quality of life after prostate cancer radiation therapy.
Clinical Trial
May 29, 2026 0
Longevity & Aging
Pfizer-BioNTech Pivotal Trial Confirms BNT162b2 Safety and Efficacy Across Ages
The landmark Phase 1/2/3 trial that brought mRNA COVID-19 vaccination to the world, now completed with booster and variant data.
Clinical Trial
May 29, 2026 0
Cancer Research
T-VEC Plus Pembrolizumab Tested in Melanoma After Anti-PD-1 Failure
Phase 2 trial explores whether combining oncolytic virus therapy with immunotherapy can rescue patients whose melanoma progressed on PD-1 blockade.
Clinical Trial
May 29, 2026 0
Cancer Research
Whole-Cell Breast Cancer Vaccine Plus PD-1 Inhibitor Targets Treatment-Resistant Metastatic Disease
A phase I/II trial tests SV-BR-1-GM, a whole-cell cancer vaccine, combined with the checkpoint inhibitor retifanlimab in patients with metastatic breast cancer.
Clinical Trial
May 29, 2026 0
Brain Health
Duke Study Tests Blood Biomarker to Catch Alzheimer's Before Symptoms Strike
Researchers at Duke University tested a blood-based biomarker to stratify Alzheimer's patients from healthy adults, aiming to enable earlier detection.
Clinical Trial
May 29, 2026 0
Heart Health
REGENXBIO Hunts LDLR Mutations to Build a Gene Therapy Pipeline for Rare Cholesterol Disorder
A completed registry study identified and genotyped HoFH patients with LDLR mutations, laying groundwork for targeted gene therapy.
Clinical Trial
May 28, 2026 0
Brain Health
Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
Clinical Trial
May 28, 2026 0